Potential prognostic factors for predicting the chemotherapeutic outcomes and prognosis of patients with metastatic colorectal cancer

被引:19
|
作者
Zhang, Liqun [1 ]
Zhang, Jingdong [1 ]
Wang, Yuanhe [1 ]
Dong, Qian [1 ]
Piao, Haiyan [1 ]
Wang, Qiwei [1 ]
Zhou, Yang [1 ]
Ding, Yang [1 ]
机构
[1] China Med Univ, Liaoning Canc Hosp & Inst, Med Oncol Dept Gastrointestinal Tumors, Canc Hosp, 44 Xiaohe Rd, Shenyang 110042, Liaoning, Peoples R China
关键词
chemotherapy response; colorectal cancer; FAR; PGR; prealbumin; prealbumin to globulin; LONG-TERM SURVIVAL; GLOBULIN RATIO; NEUTROPHIL-LYMPHOCYTE; INFLAMMATORY STATUS; PLASMA-FIBRINOGEN; ALBUMIN; PHARMACOKINETICS; RESECTION; IMPACT; TUMORS;
D O I
10.1002/jcla.22958
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Objectives The purpose of this study was to explore whether pretreatment potential prognostic factors are related to chemotherapeutic outcomes and the prognosis of inpatients with metastatic colorectal cancer (mCRC) undergoing chemotherapy. Materials and methods Data from 71 patients with mCRC were analyzed retrospectively. The relationship between the potential prognostic factors before first-line chemotherapy and the clinicopathological characteristics and chemotherapy response of the patients was calculated using Fisher's exact test and the chi-square test. The prognostic factors were analyzed using univariate and multivariate analyses. We analyzed the subgroups using the Mann-Whitney U test. Results Four factors were eventually used as prognostic factors, namely the albumin-to-globulin ratio (AGR), the fibrinogen-to-albumin ratio (FAR), the prealbumin-to-globulin ratio (PGR), and the fibrinogen-to-prealbumin ratio (FPR); the cutoff values of the four potential prognostic factors were 1.40, 10.63, 5.44, and 18.49, respectively. The high AGR and PGR groups had a higher response rate than that of the low groups. Patients in the low FAR and FPR groups showed a higher objective response rate than the high FAR and FPR groups. Patients with low FPR were associated with a higher disease control rate than patients with high FPR. Higher progression-free survival (PFS) was observed in the high AGR and PGR and low FAR and FPR groups. The AGR, FAR, PGR, and FPR were considered reliable prognostic factors for PFS in a univariate analysis. Conclusions The prechemotherapy AGR, FAR, PGR, and FPR were good prognostic factors to predict the chemotherapy response and PFS in patients with mCRC.
引用
收藏
页数:13
相关论文
共 50 条
  • [11] Geriatric factors and outcomes in metastatic colorectal cancer
    Papamichael, Demetris
    Aapro, Matti
    EUROPEAN JOURNAL OF CANCER, 2017, 74 : 96 - 97
  • [12] Analysis of factors potentially predicting prognosis of colorectal cancer
    Li-Jun Jin
    Wei-Bin Chen
    Xiao-Yu Zhang
    Jie Bai
    Hao-Chen Zhao
    Zun-Yi Wang
    World Journal of Gastrointestinal Oncology, 2019, (12) : 1206 - 1217
  • [13] Analysis of factors potentially predicting prognosis of colorectal cancer
    Jin, Li-Jun
    Chen, Wei-Bin
    Zhang, Xiao-Yu
    Bai, Jie
    Zhao, Hao-Chen
    Wang, Zun-Yi
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2019, 11 (12) : 1206 - 1217
  • [14] A prognostic score predicting survival following emergency surgery in patients with metastatic colorectal cancer
    Tan, Winson Jianhong
    Lin, Wenjie
    Sultana, Rehena
    Foo, Fung Joon
    Tang, Choong Leong
    Chew, Min Hoe
    ANZ JOURNAL OF SURGERY, 2021, 91 (11) : 2493 - 2498
  • [15] Potential markers predicting bevacizumab efficacy for metastatic colorectal cancer patients.
    Suenaga, M.
    Matsusaka, S.
    Takagi, K.
    Kuboki, Y.
    Watanabe, T.
    Shinozaki, E.
    Chin, K.
    Mizunuma, N.
    Hatake, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [16] Prognostic factors of survival outcomes in colorectal cancer patients with liver metastasis
    Pimtip, Sanvarinda
    Somkit, Mingphruedhi
    Manmana, Jirajarus
    Prapai, Chengtawee
    Ekaphop, Sirachainan
    ANNALS OF ONCOLOGY, 2017, 28
  • [17] Prognostic factors in refractory metastatic colorectal cancer patients treated with Trifluridine/Tipiracil
    Koper, Agnieszka
    Wilenski, Slawomir
    Sledzinska, Paulina
    Bebyn, Marek
    Koper, Krzysztof
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (12) : 10867 - 10877
  • [18] Prognostic factors in refractory metastatic colorectal cancer patients treated with Trifluridine/Tipiracil
    Agnieszka Koper
    Sławomir Wileński
    Paulina Śledzińska
    Marek Bebyn
    Krzysztof Koper
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 10867 - 10877
  • [19] Expression of trefoil factors and TWIST1 in colorectal cancer and their correlation with metastatic potential and prognosis
    Yusup, Akram
    Huji, Bailikezi
    Fang, Cheng
    Wang, Fei
    Dadihan, Tuerxunjiang
    Wang, Hai-Jiang
    Upur, Halmurat
    WORLD JOURNAL OF GASTROENTEROLOGY, 2017, 23 (01) : 110 - 120
  • [20] Expression of trefoil factors and TWIST1 in colorectal cancer and their correlation with metastatic potential and prognosis
    Akram Yusup
    Bailikezi Huji
    Cheng Fang
    Fei Wang
    Tuerxunjiang Dadihan
    Hai-Jiang Wang
    Halmurat Upur
    World Journal of Gastroenterology, 2017, 23 (01) : 110 - 120